2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$4.15+$0.10 (+2.47%)
Price as of Jun 03, 2026 7:59 PM EDT- $264.4MMarket Cap
- 168.21%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$4.15+$0.10 (+2.47%)
MGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.05 | ||
Change | -$0.09 (-2.17%) | ||
Open | $4.13 | ||
High | $4.21 | ||
Low | $4.03 | ||
Previous Close | $4.14 | ||
Volume | 492,542 | ||
30-Day Average Volume | 1,488,651 | ||
1-Week Change | -9.40% | ||
1-Month Change | 29.39% | ||
1-Year Change | 168.21% | ||
3-Year Change | -16.67% | ||
5-Year Change | -86.96% | ||
Fundamentals | |||
Shares Outstanding | 63.6M | ||
Total Assets | $217.9M | ||
Market Cap | $264.4M | ||
Enterprise Value | $197.9M | ||
Period: QTR TTM FY | |||
Revenue | $570,000.00 | ||
Net Income | -$36.8M | ||
Free Cash Flow | -$36.2M | ||
EBIT | -$31.9M | ||
EBITDA | -$30.2M | ||
Net Working Capital | $86.6M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 347 | ||
P/B | 12 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue